VTE (Venous Thromboembolism)
10
4
4
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 10 trials
30%
3 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (10)
The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.
Venous Thromboembolism and Chronic Pain After Major Limb Trauma
A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based Regimens
DOAC - Dosing Options in AntiCoagulation Prophylaxis
Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies
Excretion of Rivaroxaban in Human Breast Milk
Padua Prediction Score for VTE Risk in Thoracic Surgery Patients
AQT90 FLEX D-dimer Clinical Sensitivity and Specificity
A Multicenter, Open-Label, Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer Surgery
Timing of VTE Prophylaxis in TBI